Elsevier Inc.

SHERPA: Unknown

People

  1. Aghajanian
    Aghajanian
  2. Norton
    Norton
  3. Mychalczak
    Mychalczak
  4. Sabbatini
    Sabbatini
  5. Seshan
    Seshan

Groups

  1. Surgery (9)
  2. Department of Medicine (7)
  3. Solid Tumor Oncology Division (7)
  4. Gynecology Disease Management Team (5)
  5. GDMT, Medicine (4)
  6. Gynecologic Medicine Service (4)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  8. Breast Medicine Service (3)
  9. Nursing (2)
  10. Biostatistics Service (1)
Search Within
  1. "David Spriggs"
  2. "William Hoskins"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. Surgery (9)
  2. Department of Medicine (7)
  3. Solid Tumor Oncology Division (7)
  4. Gynecology Disease Management Team (5)
  5. GDMT, Medicine (4)
  6. Gynecologic Medicine Service (4)

More Groups

People
  1. David Spriggs (9)
  2. William Hoskins (9)
  3. John Curtin (7)
  4. David Fennelly (5)
  5. Carol Aghajanian (4)
  6. John Lewis (4)

More People

Years
  1. 2007 (1)
  2. 1999 (1)
  3. 1997 (1)
  4. 1996 (1)
  5. 1995 (5)
Publications
  1. Gynecologic Oncology (7)
  2. European Journal of Cancer (1)
  3. Seminars in Oncology (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Significance of pretreatment CA-125 level in advanced ovarian carcinoma: A meta-analysis of seven Gynecologic Oncology Group protocols
    Meeting Abstract

    Zorn, K. K.; Armstrong, D. K.; Tian, C. Q.; McGuire, W. P.; Hoskins, W. J.; Markman, M.; Muggia, F. M.; Rose, P. G.; Ozols, R. F.; Spriggs, D.
    Gynecologic Oncology (2007)

    Fulltext@MSK | Save
  • Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
    Journal Article

    Husain, A.; Sabbatini, P.; Spriggs, D.; Fennelly, D.; Aghajanian, C.; Barakat, R.; Curtin, J.; Venkatraman, E.; Hoskins, W.; Markman, M.
    Gynecologic Oncology (1999)

    Fulltext@MSK | Save
  • Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer
    Journal Article

    Fennelly, D. W.; Aghajanian, C.; Shapiro, F.; Oflaherty, C.; Oconnor, K.; Curtin, J. P.; Crown, J. P.; Hoskins, W. J.; Spriggs, D. R.
    Seminars in Oncology (1997)

    Fulltext@MSK | Save
  • The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer
    Journal Article

    Gogas, H.; Shapiro, F.; Aghajanian, C.; Fennelly, D.; Almadrones, L.; Hoskins, W. J.; Spriggs, D. R.
    Gynecologic Oncology (1996)

    Fulltext@MSK | Save
  • Combination cisplatin (P), ifosfamide (I) with mesna, and 5-fluorouracil (F) chemotherapy in advanced or recurrent cervical carcinoma
    Meeting Abstract

    Gibson, L. E.; Schneider, J.; Reichman, B.; Fennelly, D.; Hakes, T.; Barakat, R.; Curtin, J.; Jones, W.; Lewis, J. L. Jr; Norton, L.; more...
    Gynecologic Oncology (1995)

    Fulltext@MSK | Save
  • Ovarian cancer presenting in women with a prior history of breast cancer: A retrospective analysis of 53 patients
    Meeting Abstract

    Schneider, J. G.; Curtin, J. P.; Dyckman, S.; Spriggs, D.; Norton, L.; Hoskins, W.
    Gynecologic Oncology (1995)

    Fulltext@MSK | Save
  • Escalating-dose Taxol (T) plus high-dose (HD) cyclophosphamide (C) plus G-CSF (G) followed by rapidly sequences courses of HD carboplatin (CBDCA) plus C rescued with peripheral blood progenitor cells (PBP) in patients with stage IIC-IV ovarian cancer (OC)
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Bengala, C.; Barakat, R.; Curtin, J.; Jones, W.; Lewis, J. L. Jr; Spriggs, D.; Hoskins, W.; Norton, L.
    Gynecologic Oncology (1995)

    Fulltext@MSK | Save
  • Long-term follow-up of phase II trial of adjuvant chemotherapy and whole pelvic radiation therapy after radical hysterectomy and pelvic lymphadenectomy (RH PLND) for high-risk patients with cervical cancer
    Meeting Abstract

    Curtin, J.; Lewis, J. L. Jr; Hoskins, W.; Jones, W.; Mychalczak, B.; Spriggs, D.
    Gynecologic Oncology (1995)

    Fulltext@MSK | Save
  • Phase I study of Taxol administered weekly in patients with persistent ovarian cancer
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Spriggs, D.; Aghajanian, C.; Francis, P.; Lewis, J. L.; Jones, W.; Curtin, J.; Barakat, R.; Hoskins, W.
    European Journal of Cancer (1995)

    Fulltext@MSK | Save